iShares MSCI Hong Kong ETF vs Personalis Inc. Common Stock — how do they compare? iShares MSCI Hong Kong ETF trades at $21.92 (market cap $1.19B), while Personalis Inc. Common Stock trades at $16.07 (market cap $1.69B). The key difference: Personalis Inc. Common Stock is the larger of the two by market cap, and Personalis Inc. Common Stock is trading nearer its 52-week high, iShares MSCI Hong Kong ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Hong Kong ETF for 63 Days and Personalis Inc. Common Stock for 0 Days on average.
| EWH | PSNL | |
|---|---|---|
Market Cap | $1.19B | $1.69B |
Volume | 2,118,222 | 3,817,236 |
Sector | Broad Market / Factor | Health |
52-Week High | $24.55 | $18.38 |
52-Week Low | $20.92 | $5.04 |
Typical Hold Time | 63 Days | 0 Days |
Enterprise Value | — | $1.52B |
Signals from Pluang's Aura AI — not financial advice
EWH, the iShares MSCI Hong Kong ETF, trades at $22.35 with a 1.78% daily gain amid bearish technical signals. The ETF faces headwinds from Hong Kong's Hang Seng Index decline, down over 11% from yearly highs due to Federal Reserve policy and US-Iran tensions. Technical indicators show mixed signals with bearish moving averages but neutral oscillators, while support and resistance cluster tightly around $22.
The outlook remains cautious given Hong Kong's market volatility and geopolitical risks. Investment opportunity exists for contrarian bets on Chinese tech recovery, but risks include sustained Fed tightening and regional tensions. Wall Street sentiment is divided, with some seeing value in oversold conditions while others warn of further downside.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →